Liquid Biopsy For Noninvasive Multi-Cancer Detection And Characterization In Dogs

Blood-based liquid biopsy for veterinary applications will be introduced, including a review of the current clinical approach to cancer diagnosis, and opportunities for cell-free DNA based liquid biopsy testing in dogs. Multiple clinical use cases for liquid biopsy in cancer detection will be described, including screening for early detection; aid in diagnosis; and monitoring for residual or recurrent disease.

Learning Objectives:

1.      Describe the origins of cell-free DNA (cfDNA) in the setting of cancer

2.      Identify clinical scenarios in which liquid biopsy testing may be useful

3. Recognize areas for future research in the field of veterinary oncology diagnostics

**Click Here** to register

Approved for ONE hr California Statutorily Approved CE

SPEAKER: Andi Flory, DVM, DACVIM (Oncology)

Dr. Andi Flory is a board-certified specialist in Medical Oncology. Dr. Flory graduated from The Ohio State University College of Veterinary Medicine and completed additional training at Florida Veterinary Specialists and Cancer Treatment Center in Tampa, Florida, and Cornell University in Ithaca, NY.  Dr. Flory has previously worked as an oncologist in the US and Australia until a little dog named Poppy changed the path of her career and led her to a passion for cancer genomics.  Since 2019, Dr. Flory has been acting in the role of Chief Medical Officer for PetDx, which aims to bring noninvasive cancer detection to veterinary medicine.